A Clinical Trial for People HIV+ Age > 50 at Risk for Heart Disease

NCT01578772 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Endothelial Dysfunction

Interventions

DRUG: Telmisartan

Sponsor

University of California, Los Angeles

Collaborators

[object Object]